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Abstract
Synaptic functional disturbances with concomitant synapse loss represent central pathological hallmarks of Alzheimer’s 
disease. Excessive accumulation of cytotoxic amyloid oligomers is widely recognized as a key event that underlies neuro-
degeneration. Certain complement components are crucial instruments of widespread synapse loss because they can tag 
synapses with functional impairments leading to their engulfment by microglia. However, an exact understanding of the 
affected synaptic functions that predispose to complement-mediated synapse elimination is lacking. Therefore, we conducted 
systematic proteomic examinations on synaptosomes prepared from an amyloidogenic mouse model of Alzheimer’s disease 
(APP/PS1). Synaptic fractions were separated according to the presence of the C1q-tag using fluorescence-activated syn-
aptosome sorting and subjected to proteomic comparisons. The results raised the decline of mitochondrial functions in the 
C1q-tagged synapses of APP/PS1 mice based on enrichment analyses, which was verified using flow cytometry. Additionally, 
proteomics results revealed extensive alterations in the level of septin protein family members, which are known to dynami-
cally form highly organized pre- and postsynaptic supramolecular structures, thereby affecting synaptic transmission. High-
resolution microscopy investigations demonstrated that synapses with considerable amounts of septin-3 and septin-5 show 
increased accumulation of C1q in APP/PS1 mice compared to the wild-type ones. Moreover, a strong positive correlation 
was apparent between synaptic septin-3 levels and C1q deposition as revealed via flow cytometry and confocal microscopy 
examinations. In sum, our results imply that deterioration of synaptic mitochondrial functions and alterations in the organi-
zation of synaptic septins are associated with complement-dependent synapse loss in Alzheimer’s disease.
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Mitochondrial dysfunction · Septins
Abbreviations
2D-DIGE  Two-dimensional difference gel 
electrophoresis
AD  Alzheimer’s disease
APC  Allophycocyanin
APP  Amyloid precursor protein
Aβ  Amyloid-beta
BSA  Bovine serum albumin
Cy  Cyanine
FITC  Fluorescein isothiocyanate
FSC  Forward light scatter
GO  Gene ontology
PB  Phosphate buffer
PerCP-Cy5.5  Peridinin-chlorophyll cyanine 5.5
PMT  Photomultiplier tube
PS1  Presenilin-1
ROS  Reactive oxygen species
Sept  Septin
SET  Sucrose/EDTA/Tris
SOX  Superoxide
Cellular and Molecular Life Sciences
Katalin A. Kékesi and József Kardos contributed equally to this 
work.
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s0001 8-020-03468 -0) contains 
supplementary material, which is available to authorized users.
 * József Kardos 
 kardos@elte.hu
Extended author information available on the last page of the article
 B. A. Györffy et al.
1 3
SSC  Side light scatter
Syp  Synaptophysin
TBS  Tris-buffered saline
Introduction
Alzheimer’s disease (AD) is characterized by excessive and 
persistent synapse loss, which increases during disease pro-
gression and later accompanied by widespread neuronal cell 
death that altogether lead to gradual deterioration of memory 
and other cognitive functions [1]. Importantly, the extent of 
synapse loss shows a considerably strong positive correla-
tion with impairments in cognitive functions [2]. The under-
lying pathology in overabundant synapse loss is not fully 
deciphered yet; however, accumulation of toxic amyloid oli-
gomers (formed from amyloid-beta (Aβ) 1–40 and 1–42 pep-
tides) is widely recognized as a critical causative factor [3]. 
Microglial cells, the most abundant resident macrophages in 
the brain, and the complement cascade have gained increas-
ing attention recently, focusing on the pathogenesis of AD. 
Activated “Janus-faced” microglia not just alleviate disease 
progression via clearance of Aβ [4] but also substantially 
contribute to neurodegeneration as they can amplify deleteri-
ous proinflammatory mechanisms [5] and engulf synapses 
[6]. Among microglial factors modulating neuronal func-
tions, the complement cascade has a central role. Comple-
ment components are parts of the innate immune system 
involved in the rapid elimination of harmful and unneces-
sary cellular elements, e.g., invading pathogens and cellular 
debris [7], and also expressed in the central nervous system 
[8]. Notably, C1q, the initiator of the classical complement 
pathway, is dominantly synthesized by microglia in the brain 
[9]. Certain members of the complement cascade are known 
for more than a decade to be involved in the synaptic refine-
ment in the developing visual system as they tag synapses for 
selective pruning [10]. Moreover, it has been demonstrated 
that the microglia–complement axis is substantially involved 
in pathological, excessive synaptic pruning in animal models 
of AD even in the early stages preceding the chronic neu-
roinflammatory condition [11]. Additional studies unveiled 
that beyond AD, complement conveys aberrant synapse loss 
in other disorders with exaggerated synaptic pruning, such 
as tauopathy-associated neurodegeneration [12], frontotem-
poral dementia [13], glaucoma [14], schizophrenia [15, 16], 
West Nile virus infection [17], hypoxic–ischemic brain dam-
age [18], and traumatic brain injury [19].
We currently reported that complement-mediated syn-
apse elimination is strongly dependent on the activation of 
local synaptic apoptotic-like processes in the healthy adult 
brain [20]. Nonetheless, the cellular events in the synap-
tic compartment that predispose to synaptic C1q-tagging 
and complement-mediated synapse loss under pathological 
conditions characterized by elevated synapse elimination 
remain elusive. To this end, in this study, we employed fluo-
rescence-activated synaptosome sorting coupled to proteom-
ics on the APPswe/PSEN1dE9 (APP/PS1) transgenic mouse 
model of AD. Double-transgenic APP/PS1 mice bearing 
mutant amyloid precursor protein (APP) and presenilin-1 
(PS1) genes show gradual development of several well-
known features of the disorder, e.g., amyloid plaque deposi-
tion [21, 22], impaired synaptic plasticity [23], synapse loss 
[11], memory deficits, and behavioral abnormalities [24]. 
Previously, we described in the APP/PS1 mice the proteomic 
correlates of synaptic mitochondrial dysfunction [25], a 
widely accepted early cornerstone of AD development [26]. 
Noteworthy, critical accumulation of Aβ deposits appears 
relatively earlier in this mouse model than in the most com-
mon sporadic form of AD in affected elderly patients [22], 
enabling the more specific investigation of the detrimental 
effects of Aβ with less interference with the aging process. 
Most importantly, the crucial role of complement-dependent 
synapse loss in disease development is well documented in 
this animal model [11, 27, 28]. Altogether, the APP/PS1 
mouse serves a proper subject for unveiling the molecular 
mechanisms linked to pathologically increased complement-
driven synapse loss due to overproduction of toxic amyloid 
species. We addressed this question conducting systematic 
proteomic investigations on the C1q-tagged synaptic com-
partment of APP/PS1 mice to reveal the molecular mecha-
nisms involved in neurodegeneration.
Materials and methods
Animals
The studies were carried out on 8–12  months of 
age and 24  months of age male APP/PS1 (B6C3-
Tg(APPswe,PSEN1dE9)85Dbo) and C57BL/6N (wild-type) 
mice. Animals were housed under standard laboratory con-
ditions (12:12 h light–dark cycle, with free access to water 
and food).
Preparation of the fraction of synaptosomes
Animals were transcardially perfused with ice-cold phos-
phate-buffered saline under urethane anesthesia. Their brains 
were quickly removed, and the cerebral cortices from both 
hemispheres were isolated. The fraction of synaptosomes, 
comprising the pre- and postsynaptic compartments, was 
prepared immediately from cerebral cortices according to 
the protocol of Phillips et al. [29]. Briefly, isolated cortices 
were mechanically homogenized in an isoosmotic sucrose 
medium, and then samples were subjected to density-gra-
dient centrifugation using two layers with different sucrose 
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concentrations. The synaptosomes were collected from the 
interface and stored at 4 °C until use.
Immunolabeling of synaptosomes
Freshly prepared synaptosomes were subjected to immu-
nolabeling using our previously described protocol [20]. 
In brief, synaptosomes were gently fixed using 0.25% (wt/
vol) formaldehyde in 320 mM sucrose, 1 mM EDTA, 5 mM 
Tris, pH 7.4 buffer (SET buffer). The low ionic strength of 
the SET buffer prevents synaptosome aggregation [20], and 
thus was used as the medium for the entire immunolabeling 
procedure. Lightly fixed synaptosomes were incubated with 
1% (wt/vol) bovine serum albumin (BSA) to block aspecific 
antibody–antigen interactions. Subsequently, synaptosomes 
were incubated with anti-C1QA primary antibody (1:100 
dilution; catalog number: ab155052; Abcam, Cambridge, 
UK), and then with Cy5-conjugated anti-rabbit secondary 
antibody (1:1,000 dilution; catalog number: 711-175-152; 
Jackson ImmunoResearch Laboratories, West Grove, PA, 
USA) after washing. Finally, samples were extensively 
washed, filtered through a 5.0 µm Durapore membrane filter 
(catalog number: SVLP02500; Merck Millipore, Billerica, 
MA, USA), supplemented with 0.5% (vol/vol) Pluronic 
F-68 detergent (Thermo Fisher Scientific; Waltham, MA, 
USA), and subjected to fluorescence-activated synaptosome 
sorting.
In the case of additional flow cytometry experiments, syn-
aptosome suspensions were either labeled for mitochondrial 
markers or septin-3 (Sept3) after labeling for C1q, before 
synaptosome filtration. Samples assigned for detection of 
mitochondrial functions were labeled with the mitochondrial 
marker MitoTracker Green FM (catalog number: M7514; 
Thermo Fisher Scientific) and the mitochondrial super-
oxide indicator MitoSOX Red (catalog number: M36008; 
Thermo Fisher Scientific) at the same time, according to the 
manufacturer’s instructions. To assess synaptic Sept3 levels, 
another experimental group of synaptosome fractions was 
subjected to permeabilization using SET buffer containing 
0.2% (vol/vol) Tween-20 and 1% (wt/vol) BSA. Then, synap-
tosomes were labeled first with anti-septin-3 primary (1:100 
dilution; catalog number: MABN150; Merck Millipore), 
and then Alexa Fluor 488-conjugated anti-mouse second-
ary (1:1,000 dilution; catalog number: 715-545-151; Jackson 
ImmunoResearch Laboratories) antibodies and filtered.
Flow cytometry and sorting of synaptosomes
The flow cytometry and sorting experiments were carried 
out using a BD FACSAria III cell sorter (BD Biosciences, 
San Jose, CA, USA) coupled with the BD FACSDiva soft-
ware (BD Biosciences). Droplets were generated using a 
70 µm nozzle, and synaptosomes were illuminated with a 
488 nm- and a 633 nm-wavelength laser. Parameters for 
signal detection were set as follows: forward light scat-
ter (FSC) detector photomultiplier tube (PMT) gain set-
ting = 350 V with a 1.5 neutral density filter; side light 
scatter (SSC) detector PMT gain setting = 600 V; FSC 
threshold = 5,000; SSC threshold = 2,000; fluorescein 
isothiocyanate (FITC) channel PMT gain setting = 455 V; 
peridinin-chlorophyll cyanine 5.5 dye (PerCP-Cy5.5) 
channel PMT gain setting = 580 V, and allophycocyanin 
(APC) channel PMT gain setting = 508 V. Synaptosome 
suspension dilution and flow rate were adjusted to ensure 
optimal event recordings (below 20,000 processed events 
per sec). Gating of synaptosomes was performed using 
the fluorescence intensities of non-labeled synaptosome 
suspensions, i.e., that incubated with neither the mitochon-
dria-specific dyes nor the primary antibodies but only with 
the corresponding secondary antibodies. For the sorting 
experiments, fluorescent C1q-tagged and non-fluorescent 
C1q-untagged synaptosomes were collected into separate 
tubes in “purity” sorting mode. Three million C1q-tagged 
and three million untagged synaptosomes were collected 
for the proteomics experiments from each animal. Sorted 
samples were concentrated with 100 K Amicon Ultra-15 
centrifugal filter units (Merck Millipore), and proteins 
were precipitated with the chloroform–methanol precipi-
tation method [30]. Precipitated proteins were resuspended 
in a lysis buffer (7 M urea, 2 M thiourea, 4% (wt/vol) 
CHAPS, 20 mM Tris, and 5 mM magnesium acetate, pH 
8.5) suitable for the downstream proteomics studies and 
stored at − 80 °C.
In addition, quantitative flow cytometry measurements 
were conducted to evaluate the extent of colocalization 
between synaptic C1q and Sept3 proteins and the correla-
tion between C1q and mitochondrial superoxide levels. 
Synaptically deposited C1q and synaptosomal Sept3 levels 
were assessed using the APC and FITC channels, respec-
tively. In case of the mitochondrial study, we utilized the 
FITC, PerCP-Cy5.5, and APC channels for MitoTracker 
Green, MitoSOX Red, and C1q detection, respectively, 
using a parallel laser arrangement that ensured the neces-
sary spectral separation of the fluorophores. In each exper-
imental group, multiparametric data of 250,000 single syn-
aptosomes were acquired and recorded for further analysis. 
Data processing and display were performed using FCS 
Express 6 software (De Novo Software, Glendale, CA, 
USA). Statistically significant differences between groups 
were determined with either two-tailed Student’s t-test of 
paired samples or one-way ANOVA followed by Tukey’s 
post hoc test. For analysis aiming at the evaluation of the 
correlation between synaptosomal C1q and Sept3 levels, 
we used the non-parametric Spearman’s rank correlation 
statistical test because neither of the data showed normal 
distribution.
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Proteomics investigation
The proteomic comparison of sorted synaptosomes was per-
formed using the gel-based two-dimensional difference gel 
electrophoresis (2D-DIGE) proteomics technique. In study 
#1, comparisons were carried out between the C1q-tagged 
synaptosomes of six 8–9 months of age APP/PS1 and six 
age-matched wild-type (C57BL/6N) mice. For study #2, 
the proteomes of C1q-tagged and untagged synaptosomes 
were compared, prepared from six 8–9 months of age APP/
PS1 mice. In both experiments, we performed the saturation 
labeling technique and protein separation steps, as described 
in details before [20]. In brief, synaptic proteins from the 
sorted samples were labeled with a highly sensitive cya-
nine-5 (Cy5) fluorescent dye and mixed with an internal 
control sample (pooled from the samples to be compared) 
that was labeled with the spectrally separable Cy3 dye. Pro-
tein mixtures then were subjected to protein separation, first, 
according to their isoelectric points, and then on the basis 
of their different molecular weights. Fluorescence of the 
separated proteins in the gel was recorded using a Typhoon 
TRIO + fluorescence scanner (GE Healthcare, Little Chal-
font, UK). Protein spots were detected, matched, and their 
fluorescence intensities (normalized to that of the internal 
control sample) were compared between the different sam-
ples using the DeCyder 2D Differential Analysis Software 
(GE Healthcare). Statistically significant differences were 
determined in the software with two-tailed Student’s t-test 
of independent and paired samples in study #1 and study #2, 
respectively. The significance level was set at P < 0.05. Sig-
nificantly altered protein spots that showed more than ± 1.1-
fold change between the experimental groups were assigned 
for manual excision from a preparative gel containing 800 µg 
total synaptosomal proteins. Excised gel spots were placed 
in 1% (vol/vol) acetic acid solution and stored at 4 °C until 
protein identification.
For the mass spectrometric protein identification, proteins 
were digested with Trypsin Gold (Promega, Madison, WI, 
USA) according to the protocol by Shevchenko et al. [31] 
with minor modifications. The high-performance liquid 
chromatography–tandem mass spectrometry (HPLC–MS/
MS) analysis was carried out employing a nanoflow UHPLC 
system (Dionex UltiMate 3000 RSLCnano System; Thermo 
Fisher Scientific) coupled to a high-resolution QTOF mass 
spectrometer (Maxis II ETD, Bruker Daltonik, Bremen, 
Germany). A CaptiveSpray source and a nanoBooster 
tank, filled with acetonitrile and operating with  N2-flow 
at 0.2 bar, were fitted with the mass spectrometer. Desalt-
ing was conducted online on an Acclaim Pepmap C18 trap 
column (100 μm i.d. × 20 mm; Thermo Fisher Scientific), 
and then tryptic peptides were separated on a reverse-phase 
Acclaim Pepmap RSLC analytical column (C18, 75 μm 
i.d. × 150 mm; Thermo Fisher Scientific). Peptide elution 
from the analytical column to the emitter tip was performed 
using a flow rate of 300 nL/min and a 90 min-long gradient 
ranging from 2.5% to 45% (vol/vol) solvent B (solvent “A” 
was water containing 0.1% (vol/vol) formic acid, and solvent 
“B” was acetonitrile containing 0.1% (vol/vol) formic acid). 
Mass spectrometry utilized electrospray ionization in the 
positive-ion mode. Signal intensities were measured using 
single-stage mass spectrometry with settings as follows: 
capillary voltage = 1.2 kV, drying gas flow rate = 3 L/min, 
gas temperature = 150 °C. Protein identification employ-
ing tandem mass spectrometry used the AutoMS/MS setup 
(data-dependent analysis) from the m/z range of 300–2,200. 
Collision gas was  N2, and the collision energy was varied 
in the 10–80 eV range according to predefined charge state-
dependent configuration files. Protein content, identified 
from data-dependent analysis measurements, was searched 
against the latest SwissProt sequence database using the tax-
onomy of Mus musculus employing the Mascot Server v.2.5 
(Matrix Science, London, UK). In the course of database 
searching, one missed cleavage was allowed, carbamidome-
thyl cysteine was set as a fixed modification, and methionine 
oxidation was allowed as variable modification. Identified 
proteins were accepted if a minimum of two unique pep-
tides were accurately identified. For protein data analysis, 
we used ProteinScape v3.0 bioinformatics platform (Bruker, 
Billerica, MA, USA).
Bioinformatics analysis
The biological function and subcellular localization of the 
identified proteins were evaluated using the Pathway Stu-
dio software (Elsevier Life Science Solutions), the Gene 
Ontology resource (GO; https ://geneo ntolo gy.org/), and the 
UniProt Knowledgebase (https ://www.unipr ot.org/). Enrich-
ment analyses were conducted using the Pathway Studio 
software via the “Sub-Network Enrichment Analysis” tool 
utilizing databases of both the Pathway Studio and the GO 
knowledgebase. Accordingly, we addressed cell processes, 
protein and small molecule regulators, and diseases that are 
most probably linked to the analyzed protein datasets. The 
analysis is based on the calculation of a series of Fisher’s 
exact tests using 2 × 2 matrices. During each calculation, 
the matrix contains the number of altered proteins from our 
experimental data grouped as either related or unrelated to 
the particular entity (i.e., cell process, protein and small mol-
ecule regulator, or disease) based on the exceptionally com-
prehensive knowledgebase of Pathway Studio. The matrix 
also involves the given entity’s total number of connections 
within the database and the total number of entities as well. 
The analysis provides probability values on how likely each 
entity in the entire database is linked to the experimen-
tal protein list. Statistically significantly enriched entities 
(P < 0.05) were ranked based on their calculated P values. 
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When up- or downstream regulators of the altered proteins 
were evaluated, the direction of the connection between the 
protein and the given entity was also taken into account. We 
also carried out an additional enrichment analysis using the 
tool of the GO Consortium (https ://geneo ntolo gy.org/). The 
PANTHER overrepresentation analysis provided statistically 
significantly enriched GO terms within our experimental 
data using Fisher’s exact test with the conservative Bonfer-
roni correction. Only GO terms with Bonferroni-corrected 
P values < 0.05 were considered as statistically significant.
Immunofluorescence staining of mouse brain 
sections
The APP/PS1 and wild-type mice were anesthetized with 
urethane and transcardially perfused first with 0.1 M phos-
phate buffer (PB), pH 7.4, and then with 2% (wt/vol) for-
maldehyde in 0.1 M PB. Next, the brains were removed, 
post-fixed in the same fixative solution for an additional 3 h 
at room temperature (RT), and then washed and stored in 
0.1 M PB containing 0.1% (wt/vol) sodium azide. Sixty-µm 
sagittal brain sections were produced with a vibratome and 
washed first with 0.1 M PB, and then Tris-buffered saline 
(TBS). Subsequently, brain sections were blocked in block-
ing buffer (100 mM L-lysine, 3% (wt/vol) BSA, 0.2% (vol/
vol) Triton X-100 in TBS, pH 7.4) for 45 min at RT and 
incubated in primary antibody buffer (100 mM L-lysine, 
1% (wt/vol) BSA in TBS, pH 7.4) with anti-C1q (1:1,000 
dilution; catalog number: 182451; Abcam), anti-Syp (1:500 
dilution; catalog number: 101 006; Synaptic Systems, Göt-
tingen, Germany), and either anti-septin-3 (1:1,000 dilution; 
catalog number: MABN1530; Merck Millipore) or anti-sep-
tin-5 (1:500 dilution; catalog number: ab69538; Abcam) pri-
mary antibodies for 48 h at 4 °C. After several washing steps 
with TBS, the sections were incubated with Alexa Fluor 
488-conjugated anti-mouse (1:400 dilution; catalog num-
ber: 715-545-151; Jackson ImmunoResearch Laboratories), 
Alexa Fluor 555-conjugated anti-rabbit (1:400 dilution; cata-
log number: A-31572; Thermo Fisher Scientific), and Cy5-
conjugated anti-chicken (1:400 dilution; catalog number: 
703-175-155; Jackson ImmunoResearch Laboratories) sec-
ondary antibodies in TBS for 3 h at RT. The brain sections 
were extensively washed with TBS, mounted on glass slides 
using AquaPoly/Mount medium (Polysciences, Warrington, 
PA, USA) and covered with cover glass (Marienfeld No. 
1.5H, catalog number: 0107222).
High‑resolution confocal microscopy and image 
analysis
Immunolabeled brain sections were examined with the 
Leica HyVolution 2 pseudo-super-resolution imag-
ing technique (Leica Microsystems, Wetzlar, Germany) 
using a Leica TCS SP8 stimulated emission depletion 
(STED) microscope equipped with a Leica HC PL APO 
100 × STED white objective (numerical aperture = 1.4). 
The Alexa Fluor 488, Alexa Fluor 555, and Cy5 dyes 
were sequentially excited at 488 nm, 552 nm, and 638 nm, 
respectively, and fluorescence images were acquired 
between 500–540 nm, 560–600 nm, and 650–690 nm, 
respectively, employing spectral detections with a hybrid 
detector. Image restoration was conducted using the Huy-
gens Pro deconvolution software, and Leica LAS X 3.1.1 
software was utilized for image analysis.
The lateral and axial dimensions of the recorded images 
were ~ 20 × 20 µm, and ~ 5 µm, respectively. To evaluate 
the degree of colocalization between synaptic C1q and 
Sept3/5 proteins, we utilized an automated, Fiji image 
analysis platform-based [32] workflow combining a series 
of its plugins. First, high-resolution microscopy images 
were subjected to segmentation. Local maxima of indi-
vidual synaptophysin (Syp), C1q, and Sept3/5 fluorescent 
spot-like objects were identified by the 3D Maxima Finder 
plugin, and then high-fidelity reconstruction of the spots 
was acquired using the “local mean” thresholding method 
in the 3D Spot Segmentation plugin. Geometrical centers 
(centroids) of the segmented Syp, C1q, and Sept3/5 spots 
were identified, and their pairwise colocalization analysis 
was performed using the JACoP (“Just Another Colocali-
zation Plugin”) [33] via calculating the distances between 
centroids. The software automatically calculated an ellip-
soid around every centroid with the maximal lateral and 
axial sizes of 200 nm and 500 nm, respectively (reflect-
ing the point spread function of the object after image 
acquisition and processing). Colocalizing spots were 
accepted if their ellipsoids were overlapped. To evaluate 
the colocalization between exclusively synaptic C1q and 
Sept3/5 proteins, the positions of C1q and Sept3/5 spots 
that colocalized with Syp as well were compared. Statisti-
cally significant differences in the degree of colocalization 
between APP/PS1 and wild-type mice were determined 
with two-tailed Student’s t-test of independent samples. 
To group segmented Sept3/5 immunopositive spots based 
on their intensities, we obtained all the spot local maxima 
values (“peaks”) and calculated the mean pixel intensity 
and standard deviation for each image according to the 
pixel intensity frequency distribution. Subsequently, spots 
were assigned to any of the twelve intensity groups that 
were defined based on their peaks’ distance from the mean 
(µ) (± 0.25-, 0.5-, 0.75-, 1.0-, 1.25-, and 1.5-fold standard 
deviation (σ), excluding the artifact-prone spots with peaks 
either below µ − 1.5σ or above µ + 1.5σ). Correlation 
between the degree of colocalization and the correspond-
ing intensity group was assessed by calculating Pearson’s 
correlation coefficient and two-tailed P value.
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Results
Marked alteration of mitochondrial protein levels 
in C1q‑tagged synapses of APP/PS1 mice
Complement-mediated synaptic pruning occurs under 
both physiological and pathological conditions. In our 
previous study, we isolated and analyzed the proteome of 
C1q-tagged and untagged synaptosomes prepared from the 
cerebral cortices of healthy, adult, wild-type mice to char-
acterize those synapses that are predisposed to complement-
dependent microglial elimination [20]. However, it is still 
unclear whether normal and aberrant synapse loss due to 
AD-related neurodegeneration can be distinguished based 
on their different synaptic functional disturbances. Thus, our 
current objective was to address whether C1q-tagged syn-
apses exhibit robust differences in their proteome between 
wild-type and APP/PS1 mice (study #1; the experimental 
scheme is shown in Fig. 1). We purified synaptosome frac-
tions from the cerebral cortices and selectively sorted immu-
nolabeled C1q-tagged synaptosomes taking advantage of our 
thoroughly validated and recently published fluorescence-
activated synaptosome sorting protocol [20]. Proteomic 
comparison of sorted synaptosomes’ lysates was performed 
with the 2D-DIGE method, and altered proteins were iden-
tified using mass spectrometry. The investigation revealed 
statistically significant alterations of 15 protein spots above 
the predefined criteria, which comprised 26 synaptic pro-
teins (Table S1). Interestingly, we observed a pronounced 
and general decrease in the level of the changed proteins in 
the APP/PS1 mice, as 12 out of the 15 protein spots showed 
lower fluorescence intensity levels in comparison with the 
wild-type mice. The proteins’ classification based on their 
cellular functions and subcellular locations unveiled that an 
outstanding portion of the identified proteins is linked to 
energy metabolism and the mitochondrial compartment (13 
out of 26 proteins; Fig. 2). 
Enrichment analysis suggested that the most probable 
cell process regulated by the identified proteins is apoptosis 
(Fig. S1). Amyloid precursor protein and hydrogen perox-
ide  (H2O2) were identified as the most likely protein and 
small molecule regulator candidates, respectively; while, AD 
was ranked first based on its probability score among the 
diseases potentially linked to the dataset (Fig. S1). Collec-
tively, enrichment analysis results reflected the AD-related 
molecular phenotype in the differentially regulated proteins 
and raised the possible impairment of the redox homeostasis 
within the synapse. Moreover, the PANTHER overrepresen-
tation test, employing a conservative statistical approach, 
concluded the sole enrichment of the GO term “pyruvate 
metabolic process” within the altered proteins. Altogether, 
the results support the idea that toxic Aβ accumulation leads 
to disturbances in mitochondrial functions that can amplify 
synaptic C1q deposition with the possible involvement of 
apoptotic mechanisms and oxidative stress.
Mitochondrial oxidative stress is linked 
to the accumulation of C1q on the synaptic surface
We also carried out the protein-level comparison of C1q-
tagged and untagged cortical synaptosomes obtained from 
APP/PS1 mice (study #2; Fig. 1) in the same manner as 
described in study #1. According to the results of the anal-
ysis, 46 protein spots showed altered levels, which were 
matched to 50 proteins identified using mass spectrometry 
(Table S2). In contrast to the previous experiment, the direc-
tions of level changes were more balanced, as we detected 17 
decreased and 29 increased protein spots in the C1q-tagged 
vs. untagged synaptosome comparison. Again, the differ-
entially regulated proteins were enriched in those that are 
coupled to energy metabolism, localized in the mitochon-
dria or both (25 out of the 50 proteins; Fig. 2). Enrichment 
analysis also highlighted apoptotic processes, in accordance 
with our prior data [20] (Fig. S2). Glucose was identified 
as the most probable small molecule regulator candidate, 
which was followed again by  H2O2 (Fig. S2). Proteins were 
Fig. 1  Experimental scheme of the high-throughput proteomic stud-
ies on sorted synaptosomes. Cerebral cortical synaptosomes, pre-
pared from wild-type and APP/PS1 mice, were immunolabeled for 
C1q, and then inherently C1q-tagged and untagged synaptosomes 
were separated using fluorescence-activated synaptosome sorting. 
In study #1, proteomic comparison of C1q-tagged synaptosomes 
was conducted between wild-type and APP/PS1 mice. Study #2 was 
designed to identify protein-level differences between C1q-tagged 
and untagged synaptosomes prepared from APP/PS1 mice
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most likely enriched in those related to schizophrenia, while 
AD was ranked second (Fig. S2). Interestingly, RAC-alpha 
serine/threonine-protein kinase (Akt1) appears as the protein 
candidate to regulate the altered proteins with the highest 
probability (Fig. S2). According to a recent study, reactive 
oxygen species (ROS) detrimentally affect synaptic Akt1-
signaling that eventually contributes to synaptic dysfunction 
in AD pathogenesis [34]. In addition, the PANTHER over-
representation analysis revealed the enrichment of the GO 
term “canonical glycolysis” along with many of its “child” 
terms, e.g., the “pyruvate metabolic process”.
Regarding mitochondrial disturbances, functional impair-
ments in mitochondria favor the local overproduction of 
ROS, the by-products of ATP generation, and hence, sub-
stantially hamper normal neuronal functions [35]. Mitochon-
drial ROS production is responsible for neuronal damage to 
a large extent because the mitochondrion is a major source 
of ROS in neurons, which has an outstandingly high ATP 
demand [36]. We investigated the correlation between syn-
aptically elevated mitochondrial ROS level and C1q-tagging 
to find the connection between mitochondrial dysfunction 
and predisposition to synaptic complement deposition. Cor-
tical synaptosomes from APP/PS1 mice were immunola-
beled for C1q and labeled with both mitochondria-specific 
and mitochondrial ROS-specific dyes. Synaptosome sus-
pensions were subjected to multiparametric flow cytometry 
analysis. After setting the gate based on the negative control 
sample, only those synaptosomes were analyzed further that 
contained mitochondria (84.38 ± 5.74% of synaptosomes 
recorded, mean ± S.E.M.; Fig. 3a). Our flow cytometry 
results revealed that the C1q-tagged subpopulation of syn-
aptosomes was almost entirely positive for the mitochondrial 
ROS-specific dye, MitoSOX Red, which becomes fluores-
cent upon oxidation by mitochondrial superoxide (SOX) 
(Fig. 3b). On the other hand, mitochondrially accumulated 
SOX alone does not necessarily attract synaptic C1q depo-
sition, as suggested by the high amount of C1q-untagged 
synaptosomes with high SOX level (Fig. 3b). It has to be 
noted that additional ROS production could occur during 
isolation of synaptosomes that might cause more Mito-
SOX Red-positivity compared to that of the in vivo state 
but likely independent of C1q deposition. The same flow 
cytometry experiments were also carried out on wild-type 
mice, showing that C1q-tagged synaptosomes are primarily 
MitoSOX Red-positive (Fig. 3c), thus suggesting that the 
C1q-tagged synapses are characterized by mitochondrial 
superoxide anion accumulation both in the wild-type and 
the Alzheimer’s disease model mouse strains. Notably, nei-
ther the expected increase in the percentage of C1q-tagged 
synaptosomes in the APP/PS1 mice nor any alteration in 
the amount of MitoSOX Red-positive synaptosomes was 
detectable employing 8 months of age mice with this tech-
nique (Fig. 3c). We extended the flow cytometry experi-
ments to 24 months old APP/PS1 and wild-type mice to 
Fig. 2  Mitochondrial and 
energy metabolism-related 
proteins identified in the two 
studies. On the schematic illus-
tration of synaptosomes com-
prising a presynaptic compart-
ment with mitochondrion and a 
pool of synaptic vesicles oppo-
sitely to the postsynaptic part, 
the entire list of altered proteins 
is presented as ellipses. Proteins 
are placed according to their 
known subcellular locations 
in case of the mitochondrial 
and synaptic vesicle-related 
ones, while other proteins were 
distributed throughout the 
pre- or postsynaptic cytoplasm. 
The illustration focuses on the 
wide array of mitochondrial and 
energy metabolism-related pro-
teins identified in both studies 
and colored based on the degree 
of their level changes
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gain insight into the well-known age-dependent and Aβ 
accumulation-related [11] increase of synaptic C1q-tag-
ging and to investigate its hypothesized connection with 
impaired mitochondrial functions. Our additional experi-
ments again demonstrated the preferential accumulation of 
C1q on synapses with compromised mitochondrial functions 
in both mouse strains (Fig. 3c). Moreover, we observed a 
statistically significantly higher accumulation of C1q onto 
synapses in aged APP/PS1 mice in comparison with the 
aged wild-type ones suggesting overactivation of the com-
plement within the cerebral cortex (Fig. 3d). The enhanced 
synaptic C1q-deposition was accompanied by a statistically 
significant elevation in the number of MitoSOX Red- and 
C1q double-positive synaptosomes among the MitoSOX 
Red-positive ones in comparison with the wild-type mice, 
strongly implying that increased C1q-accumulation in severe 
neurodegeneration targets synapses with dysfunctional mito-
chondria (Fig. 3e). To summarize the flow cytometry results, 
high mitochondrial superoxide level in the C1q-tagged syn-
apses is presumably a general and mouse strain-independent 
phenomenon. Importantly, age-dependent excessive C1q 
binding to the synapse in the APP/PS1 mice primarily tar-
gets synapses possessing dysfunctional mitochondria.
Fig. 3  C1q-tagged synaptosomes of APP/PS1 mice are characterized 
by elevated mitochondrial superoxide levels. a Representative over-
laid histograms show the results of the flow cytometry analysis of 
APP/PS1 mice synaptosomes labeled with the mitochondrial marker 
MitoTracker Green. Based on the gating criterion set according to the 
fluorescence intensity of the unlabeled sample, 84.38 ± 5.74% of the 
synaptosomes contained mitochondria. b Representative density plot 
of APP/PS1 mouse synaptosomes with mitochondrial content demon-
strating that the vast majority of C1q-tagged synaptosomes possesses 
mitochondria with excessive superoxide levels. The plot is based on 
the labeling results for C1q and the mitochondrial superoxide indica-
tor MitoSOX Red and gating parameters were set according to the 
unlabeled samples. The bar graph shows the statistically significant 
difference between C1q and MitoSOX Red double-labeled and C1q-
tagged but MitoSOX Red-negative synaptosome amounts. c Addi-
tional summarized flow cytometry results involving synaptosome-
labeling data of 8 and 24  months of age wild-type and APP/PS1 
mice. Each quadrant shows the percentage of the labeled population, 
as indicated in the gray quadrants on the left. d, e The bar graphs 
show the statistically significant differences in the percentage of 
C1q-tagged synaptosomes between animal groups [F (3, 13) = 3.55, 
P = 0.0451] and in the percentage of MitoSOX Red and C1q double-
labeled synaptosomes among the MitoSOX Red-positive ones [F (3, 
13) = 414.93, P = 0.0288], respectively. Means ± S.E.M. are shown. 
n = 4–5 mice per animal group. Two-tailed Student’s t-test of paired 
samples (b) and one-way ANOVA followed by Tukey’s post hoc test 
(d and e) were used for the comparisons
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Together, the great extent of mitochondrial protein-level 
changes and the detected oxidative stress condition in almost 
all of the C1q-tagged synaptosomes strongly supports the 
idea of mitochondrial functional imbalance in the back-
ground of synaptic C1q accumulation in APP/PS1 mice.
Accumulation of septin proteins in the C1q‑tagged 
synapses of APP/PS1 mice
Further evaluation of the proteomic dataset obtained from 
the comparison of C1q-tagged and untagged synaptosomes 
from APP/PS1 mice pointed out the strikingly high enrich-
ment of septin proteins (identification of Sept3, Sept4, 
Sept5, Sept7, and Sept11; Table S2). Septins are known as 
multifunctional intracellular GTPases capable of forming 
filamentous and ring-like hetero-oligomeric structures [37]. 
In the presynaptic compartment, septins (e.g., Sept3, Sept4, 
and Sept5) are involved in the regulation of synaptic vesicle 
exocytosis and recycle [38–40]. Postsynaptically, certain 
septin family members (e.g., Sept7 and Sept11) form a pro-
tein assembly that serves as a physical barrier close to the 
bases of dendritic spines [41, 42]. Due to their fundamental 
synaptic roles and marked alteration in our study, we further 
sought to investigate septins. Among them, the presynapti-
cally enriched Sept3 [43] was assigned for the examinations 
first because it showed an extensive and exceptionally high 
elevation in its levels in the C1q-tagged synaptosomes com-
pared to the untagged ones: the increased Sept3 abundance 
was detected in four protein spots with a 3.24-fold increase 
in one of them (Table S2). Synaptosome fractions from 
APP/PS1 mice were double-labeled for C1q and Sept3, and 
their co-occurrence was quantitatively assessed using flow 
cytometry. The resulting data showed a remarkably strong 
positive correlation between synaptosomal C1q and Sept3 
levels (Spearman’s rank correlation coefficient of samples 
p= 0.73 ± 0.03, mean ± S.E.M.; two-tailed P < 0.0001 for 
each sample; Fig. 4). This result implies that synaptic Sept3 
accumulation facilitates extracellular C1q deposition onto 
the synapse.
To investigate this phenomenon with a complementary 
approach, we carried out immunolabeling and high-res-
olution confocal microscopy of cerebral cortical sections 
of APP/PS1 and wild-type mice. First, we evaluated the 
extent of colocalization between synaptic C1q and Sept3 
for both mouse strains. Although Sept3 is assumed to be a 
core component of the presynapse, its analysis was limited 
to those with a considerable amount in close proximity of 
Syp “spots” (Fig. 5a). We observed a higher level of synaptic 
Sept3 colocalizing with synaptic C1q in APP/PS1 mice com-
pared to that in wild-type mice (1.30 ± 0.08-fold increase, 
mean ± S.E.M.; P = 0.0040; Fig. 5b). Similarly, elevated colo-
calization of total Sept3 and C1q proteins was seen in APP/
PS1 mice, regardless of their synaptic or non-synaptic locali-
zation (1.24 ± 0.07-fold increase, mean ± S.E.M.; P = 0.0049; 
Fig. 5b). These latter data propose that overproduced C1q 
preferentially accumulates in regions with high Sept3 content 
even on other neuronal cell compartments besides the syn-
apse (e.g., axons or cell soma). An increased amount of C1q-
tagged synapses was also apparent in the AD mouse model 
compared to the wild-type mice (1.50 ± 0.24-fold increase, 
mean ± S.E.M.; P = 0.0321), in accordance with prior data 
[11]. Additionally, we tested whether the elevated synaptic 
Fig. 4  Accumulation of Sept3 in the C1q-tagged synaptosomes. a 
Representative flow cytometry density plot showing the fluorescence 
intensity of solely secondary antibody-labeled, negative control syn-
aptosomes on the relevant fluorescence channels. b According to 
the gating criteria, the fluorescence of synaptosomes simultaneously 
labeled for C1q and Sept3 was evaluated. A strong positive correla-
tion is apparent between synaptic C1q and Sept3 levels (analysis of 
synaptosomes in the top right quadrant: ρ = 0.73 ± 0.03, P < 0.0001 
for each sample), and synaptic C1q shows remarkable colocalization 
with Sept3 on individual synaptosomes. The bar graph on the right-
hand side demonstrates the statistically significant difference between 
C1q and Sept3 double-labeled and Sept3-lacking C1q-tagged synap-
tosomes. Means ± S.E.M. are shown. n = 5 APP/PS1 mice. For each 
biologically independent sample, Spearman’s rank correlation anal-
ysis was used for assessing the correlation between C1q and Sept3 
levels, while statistically significant correlations were identified by 
determining the corresponding two-tailed P values. Two-tailed Stu-
dent’s t-test of paired samples was used for comparison between 
quadrants
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Sept3 levels are linked to more abundant C1q deposition, as 
revealed by the flow cytometry data. To this end, synaptic 
Sept3 immunopositive spots were subdivided into twelve 
different groups ranging from the faintest to the brightest 
ones (Fig. 5c). Subsequently, the extent of colocalization with 
synaptic C1q was assessed for Sept3 group-wise. Supporting 
our flow cytometry results, we observed a moderately strong 
positive correlation between Sept3 levels and the degree of 
colocalization with C1q in APP/PS1 mice (Pearson’s corre-
lation coefficient of means, R = 0.62; two-tailed P = 0.0326; 
Fig. 5d). In other words, synapses with higher Sept3 content 
are more likely to possess C1q than those with lower Sept3 
levels. Similarly, this positive correlation was also appar-
ent in the case of wild-type mice to an even larger extent 
(R = 0.89, two-tailed P = 0.0001; Fig. 5d).
To investigate further the presynaptic machinery Sept3 
takes part in, we conducted additional examinations focus-
ing on Sept5, which also showed elevated abundance in the 
C1q-tagged synaptosomes compared to the untagged ones 
in APP/PS1 mice (Table S2). In line with our results on 
Sept3, we observed enhanced colocalization of synaptic and 
total Sept5 proteins with C1q (1.19 ± 0.11-fold increase, 
P = 0.0444 and 1.61 ± 0.31-fold increase, P = 0.0402, respec-
tively; means ± S.E.M.; Fig. S3a). However, contrasting with 
Sept3, no correlation was detected in synaptic Sept5 level 
and the degree of colocalization with C1q (Fig. S3b).
Taken together, the enhanced synaptic C1q deposition 
simultaneously with the elevation in the percentage of C1q-
colocalizing synaptic Sept3 and Sept5 highly suggest that syn-
aptic C1q accumulation in APP/PS1 mice occurs preferentially 
on synapses with considerable amounts of certain septins.
Discussion
Excessive synapse loss is a hallmark of AD, which devel-
ops early in disease progression and profoundly linked to 
compromised cognitive functions. The robust appearance 
Fig. 5  C1q accumulation in APP/PS1 mice is linked to Sept3 levels 
as demonstrated by immunostaining. a Representative high-resolution 
confocal microscopy image showing C1q, Sept3, and the synaptic 
marker Syp labeling in the cortical neuropil. To enable automatic 
colocalization analyses, labeling pattern was reconstructed for each 
protein. White circles indicate positions of colocalizations between 
the three proteins. b Bar graphs showing a statistically significant 
elevation in the percentage of synaptic and total Sept3 that colocal-
ize with C1q in APP/PS1 mice compared to the wild-type ones. c 
Subdivision of Sept3 spots according to their fluorescence intensi-
ties as illustrated on a histogram showing spot counts as a function 
of the pixel intensity value of each spot’s local maximum. The mean 
pixel intensity (µ) and the standard deviation (σ) were determined for 
each image, groups were created, and every Sept3 spot was assigned 
to any of the groups based on its local maximum’s position on the 
pixel intensity range as depicted on the microscope images below. d 
Line graph demonstrating the correlation between the percentage of 
synaptic Sept3 colocalized with C1q and Sept3 levels based on the 
twelve predefined signal intensity ranges. A statistically significant 
positive correlation was revealed in both APP/PS1 and wild-type 
mice. Scale bar is 0.5 µm. Means ± S.E.M. are shown. n = 4–6 images 
from 2–3 animals per mouse strain. Two-tailed Student’s t-test of 
independent samples was used for the comparisons. Pearson’s corre-
lation coefficient (R) and the two-tailed P value were determined for 
the correlation analyses
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of gradually aggravating synapse elimination even enables 
it to be employed as a biomarker of the disease using a non-
invasive imaging technique [44]. Consequently, uncovering 
background mechanisms that pose an increased risk for ele-
vated, widespread synaptic dysfunction and ensuing synapse 
removal is of great importance to design efficient therapeutic 
strategies aiming the preservation of normal cognitive func-
tions. Increased accumulation of cytotoxic Aβ aggregates in 
brain parenchyma due to elevated production and inefficient 
clearance is widely considered as a direct cause of synaptic 
failure [45]. Synaptotoxicity of amyloidogenic products is 
mainly attributed to the oligomeric form of Aβ (reviewed 
in [46]), and it was demonstrated that the amount of syn-
aptically localized oligomeric Aβ positively correlates with 
excitatory synapse loss [47]. According to a growing body of 
data, damaged synapses became predisposed to engulfment 
by surrounding cells with phagocytic activity (mostly by 
microglia), which is even more pronounced as neuroinflam-
mation arises due to the critical accumulation of amyloid 
plaques and neurofibrillary tangles [6]. The complement 
system recently emerged as one of the essential tools for 
surveilling microglia to aid the recognition of eliminable 
synapses. Analogous to their defensive roles peripherally, 
brain-derived complement components tend to deposit onto 
toxic amyloid plaques and neurofibrillary tangles [48]. In 
addition, upregulated local complement components also 
target synapses and directly cause pathological synaptic 
pruning. The assumed hypothesis on their role in enhanced 
synapse elimination is cemented by studies demonstrating 
protection against overabundant synapse loss via selective 
blocking of complement C1q [11] and genetic deletion of 
either C1q [11, 49], complement C3 [11, 27], or C3 recep-
tor [11].
In our current study, we aimed to interrogate functional 
disturbances that predispose to Aβ-induced and comple-
ment-dependent microglial synapse removal. For this, we 
employed our recently optimized fluorescence-activated 
sorting procedure of cerebral cortical synaptosomes [20]. 
This workflow allows the reliable quantification of minute 
amounts of synaptic proteins, which is crucial due to the low 
protein yield of sorted C1q-tagged synaptosomes prepared 
from mice. Although the utilized 2D-DIGE gel-based prot-
eomic technique provides excellent sensitivity for identify-
ing even slight alterations in protein levels from low sample 
amounts [50], the coverage of the observable synaptic pro-
teome is not complete. This limitation is rooted in the well-
known obstacles of traditional 2D gel electrophoresis that 
prevent the routine detection of particular protein groups, 
e.g., hydrophobic membrane proteins and low-abundant ones 
[51]. Thus, false-negative proteins might have to be taken 
into consideration using this high-throughput approach, and 
proper validation experiments are necessary.
Our first study, addressing the molecular differences 
between C1q-tagged synaptosomes of wild-type and APP/
PS1 mice, raised the general impairment of mitochondrial 
functions in the AD animal model. Additionally, enrichment 
of mitochondria-localized proteins was also apparent in the 
second study examining proteomic differences between 
C1q-tagged synaptosomes of APP/PS1 mice compared to 
untagged ones. Functional disturbances of the mitochondria, 
caused by, e.g., damage to the mitochondrial DNA and age-
related functional decline can ultimately lead to increased 
mitochondrial ROS production that damages mitochon-
drial macromolecules and conveys elevated vulnerability 
for further adverse effects [52, 53]. Thus, the detection of 
mitochondrial ROS can provide insight into the general 
functional state of the mitochondrion. Mitochondria in 
C1q-tagged synaptosomes unambiguously showed elevated 
ROS levels, supporting the prevailing hypothesis that Aβ 
accumulation impairs synaptic mitochondrial functions. 
Amyloid precursor protein is capable to be translocated to 
the mitochondria [54] and can give rise to the deleterious 
over-production of Aβ locally, which targets many essential 
mitochondrial proteins (reviewed in [55]) and also induces 
extensive alterations in the mitochondrial proteome [25]. 
The pivotal role of mitochondria-related disturbances in AD 
is also supported by additional data demonstrating an out-
standing enrichment of key AD-associated proteins, APP 
and presenilins, in the mitochondria-associated endoplasmic 
reticulum membrane [56]. This cell compartment exhibits 
early AD-linked proteomic changes in APP/PS1 mice [57]. 
It has been shown that the Aβ-elicited extensive synaptic 
failure leads to the manifestation of apoptosis-related pro-
cesses in the synapse [58] and first increases synaptic C1q, 
and then C3 deposition [11]. “Eat-me” signals for comple-
ment components, such as externalized phosphatidylserine 
[59], could mark apoptotic synapses for C1q deposition [20]. 
However, the specific apoptotic pathway that triggers the 
apoptotic molecular cascade in the synapse prior to comple-
ment deposition remains unknown. According to the pre-
sented results, we suggest that the intrinsic, mitochondrion-
dependent apoptotic cascade could markedly contribute to 
the Aβ-induced complement-mediated synapse loss. Never-
theless, future studies are required to clarify the exact role 
of the intrinsic pathway and to address whether the extrin-
sic arm of apoptosis is involved as well. In sum, our novel 
data links the mitochondrial theory of AD to the previously 
reported aggravating complement-dependent synapse loss 
characteristic for AD.
Besides mitochondrial disturbances, our proteomics 
and subsequent validation experiments clearly pointed to 
the involvement of the septin protein family in synaptic 
C1q deposition in AD-related pathology. Sept3 and Sept5 
were not identified in study #1 but in study #2, and a higher 
degree of colocalization between synaptic Sept3/5 and C1q 
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was described in the APP/PS1 mice compared to the wild-
type ones. These results altogether suggest that although 
C1q-tagged synapses in the investigated mouse strains 
exhibit no overall major differences in their Sept3/5 levels, 
Sept3 and Sept5 accumulation is connected to a larger extent 
to synaptic C1q deposition in the AD animal model com-
pared to the healthy mice. Interestingly, certain septins show 
accumulation at neurofibrillary tangles [60], and differen-
tial expression of septins have been observed in neocortical 
protein lysates of AD patients compared to controls [61]. 
Septins are fundamentally engaged in substantial synaptic 
functions. Presynaptic septins tightly regulate synaptic vesi-
cle trafficking and exocytosis; moreover, neurite growth and 
maintenance (reviewed in [39]). Some of their postsynaptic 
counterparts influence formation of functional dendritic pro-
trusions (Sept6 [62], Sept7 [63, 64], and Sept11 [41]), and 
Sept7 is reported to effectively suppress the lateral move-
ment of membrane proteins by forming a barrier at the base 
of the dendritic spine [42]. We identified increased levels of 
Sept3, Sept5, Sept7, and Sept11 and decreased abundance 
of Sept4 in C1q-tagged synapses in comparison with the 
untagged ones in APP/PS1 mice (Table S2). Among them, 
we demonstrated the C1q-linked accumulation of Sept3 in 
the synapses and the enhanced colocalization of both Sept3 
and Sept5 with C1q in the AD animal model in compari-
son to the wild-type mice. Although the absence of Sept3 
and Sept5 does not affect negatively the proper synaptic 
transmission, possibly due to functional redundancy among 
septin proteins [65], their overabundant presence could 
be detrimental and eventually attract C1q. In agreement, 
experimental data demonstrated that Sept5 is an inhibitor 
of vesicle exocytosis [66] and prevents docking and exocy-
tosis of synaptic vesicles by forming a filamentous barrier in 
immature synapses [67]. Accordingly, forchlorfenuron treat-
ment, which specifically inhibits disassembly of the other-
wise dynamic septin filaments leading to abnormally large 
septin polymers and clusters, potently decreases presynaptic 
neurotransmitter secretion [40]. Interestingly, overexpression 
of Sept5 causes neurodegeneration and a phenotype of par-
kinsonism by occluding dopamine release [68] and induc-
ing cell death [69]. The potential synaptic effect of elevated 
Sept3 level, however, is still obscure. On the other hand, pol-
ymorphism of Sept3 gene is associated with susceptibility to 
AD [70]. In addition, overexpressed Sept3 was demonstrated 
to form a filamentous structure in complex with Sept5 and 
Sept7 [71]. Taken together, these data raise the possibility 
that the build-up of presynaptic complexes comprising Sept3 
and Sept5 might interfere with synaptic vesicle exocytosis, 
thus compromising synaptic transmission. Considering that 
low-activity synaptic contacts are predisposed to comple-
ment-mediated pruning [72], septin accumulation might 
convey elevated vulnerability to synaptic pruning by weak-
ening the synapses.
The observed higher abundance of two constituents of 
the dendritic barrier, namely Sept7 and Sept11 in C1q-
tagged synaptosomes suggests that molecular barriers 
might separate eliminable synapses from other parts of the 
dendritic branch. Taking into account that complement-
tagged synapses show the molecular signatures of apop-
totic-like processes [20], it can be hypothesized that this 
diffusion barrier might help to isolate and localize apop-
totic compartments from other areas of the arborized neu-
rites and the cell body. Spatial restriction of the apoptotic 
cascade’s propagation is crucial in maintaining the segre-
gation of functional and dysfunctional areas of the cell. 
It has already been unveiled that the proteasomes criti-
cally contribute to preventing the erroneous reverse spread 
of apoptotic signaling from the synapse to the cell body 
[73]. Based on our results, septins could emerge as further 
players in this isolation process. Alternatively, it can also 
be hypothesized that the causal relationship’s direction is 
the opposite, and exaggerated accumulation of dendritic 
septins leads to synaptic dysfunction via obstructing mem-
brane protein trafficking required to ensure synaptic plas-
ticity. Finally, future studies will be needed to examine 
in detail alterations in synaptic Sept4 levels in relation to 
neurodegeneration-associated synapse loss. Intriguingly, 
one of its isoforms, the mitochondrion-localized ARTS, is 
known to effectively regulate apoptosis and translocate to 
the nucleus due to pro-apoptotic stimuli [74].
The direct effect of Aβ and the mechanistic steps that 
eventually lead to septin accumulation remain elusive. 
Similarly, the connection between mitochondrial processes 
and the organization of the synaptic septins also has to 
be clarified. However, previous studies demonstrated the 
capability of mitochondria to organize septin polymer for-
mation [75] and the potential of septins to regulate mito-
chondrial fission [76] in non-neuronal cells.
In sum, our current results shed light on and emphasize 
the importance of the imbalance in mitochondrial func-
tions and the organization of septins within the synap-
tic compartment in AD-related, complement-mediated 
synapse loss. We propose a model showing neurotoxic 
Aβ accumulation-induced mitochondrial impairments 
and septin-related changes that can result in the already 
revealed activation of local apoptotic-like mechanisms and 
subsequent synaptic C1q deposition (Fig. 6).
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